SOPHiA GENETICS SA (SOPH) Misses Q3 EPS by 6c; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- Goldman data shows hedge funds cut leverage at fastest pace since March
Tweet
Share
E-mailGet Alerts SOPH Hot Sheet
Join SI Premium – FREE
SOPHiA GENETICS SA (NASDAQ: SOPH) reported Q3 EPS of ($0.24), $0.06 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $24.26 million versus the consensus estimate of $24.03 million.
GUIDANCE:
SOPHiA GENETICS SA sees FY2026 revenue of $94-96 million, versus the consensus of $95.23 million.
For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IPG Photonics (IPGP) Tops Q3 EPS by 15c ; Offers Guidance
- Pfizer increases annual profit forecast amid solid demand for blood thinner drug
- Anthropic To Have Over 3.5Gw Computing Power By End 2026 - NYT
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
